Volution Group plc Total Voting Rights (3251I)

TIDMFAN

RNS Number : 3251I

Volution Group plc

01 December 2022

1 December 2022

Volution Group plc

Total Voting Rights

Volution Group plc ("Volution" or the "Company", LSE: FAN), a leading international designer and manufacturer of energy efficient indoor air quality solutions, would like to notify the market in accordance with the Financial Conduct Authority's ("FCA's") Disclosure Guidance and Transparency Rules, of the following information as at the date of this announcement:

The Company's issued share capital consists of 200,000,000 ordinary shares of 1 pence each with each share carrying the right to one vote. The Company currently holds 2,377,675 ordinary shares in Treasury. Therefore, the total number of voting rights in the Company is 197,622,325.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. Any such notifications should be sent to the following email address: [e-mail] , marked for the attention of the Company Secretary.

- ends -

Enquiries:

Volution Group plc

Fiona Smith, Company Secretary

Legal Entity Identifier: 213800EPT84EQCDHO768

Note to Editors:

Volution Group plc (LSE: FAN) is a leading international designer and manufacturer of energy efficient indoor air quality solutions.

Volution Group comprises 19 key brands across three regions:

UK: Vent-Axia, Manrose, Diffusion, National Ventilation, Airtech, Breathing Buildings, Torin-Sifan.

Continental Europe: Fresh, PAX, VoltAir, Kair, Air Connection, Rtek, inVENTer, Ventilair, ClimaRad, ERI Corporation.

Australasia: Simx, Ventair, Manrose.

For more information, please go to: www.volutiongroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRGZMGZVMMGZZM

(END) Dow Jones Newswires

December 01, 2022 11:05 ET (16:05 GMT)